104 related articles for article (PubMed ID: 35256883)
1. Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection.
Corcillo A; Saqib A; Sithamparanathan N; Khanam A; Williams J; Gulati A; Kariyawasam D; Karalliedde J
Int J Endocrinol; 2022; 2022():8030765. PubMed ID: 35256883
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic Treatment before Hospitalization and Admission Parameters in Patients with Type 2 Diabetes, Obesity, and SARS-CoV-2 Viral Infection.
Reștea PA; Mureșan M; Voicu A; Jurca T; Pallag A; Marian E; Vicaș LG; Jeican II; Crivii CB
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983573
[TBL] [Abstract][Full Text] [Related]
3. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
4. The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis.
Heald AH; Jenkins DA; Williams R; Sperrin M; Fachim H; Mudaliar RN; Syed A; Naseem A; Gibson JM; Bowden Davies KA; Peek N; Anderson SG; Peng Y; Ollier W
Diabetes Ther; 2022 May; 13(5):1007-1021. PubMed ID: 35325361
[TBL] [Abstract][Full Text] [Related]
5. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
6. Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors.
Heald AH; Jenkins DA; Williams R; Sperrin M; Mudaliar RN; Syed A; Naseem A; Bowden Davies KA; Peng Y; Peek N; Ollier W; Anderson SG; Delanerolle G; Gibson JM
Diabetes Ther; 2022 May; 13(5):1037-1051. PubMed ID: 35416588
[TBL] [Abstract][Full Text] [Related]
7. Ethnic variation in outcome of people hospitalised during the first COVID-19 epidemic wave in Wales (UK): an analysis of national surveillance data using Onomap, a name-based ethnicity classification tool.
Thomas DR; Orife O; Plimmer A; Williams C; Karani G; Evans MR; Longley P; Janiec J; Saltus R; Shankar AG
BMJ Open; 2021 Aug; 11(8):e048335. PubMed ID: 34408047
[TBL] [Abstract][Full Text] [Related]
8. The Trend of High-Dose Insulin Usage Among Patients with Diabetes in the UK: A Retrospective Study.
Idris I; Peng X; He X; Liu D; Balogh E; Kaushik P; Van Brunt K
Diabetes Ther; 2018 Dec; 9(6):2245-2257. PubMed ID: 30269224
[TBL] [Abstract][Full Text] [Related]
9. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.
Casillas Santana MA; Arreguín Cano JA; Dib Kanán A; Dipp Velázquez FA; Munguía PDCS; Martínez Castañón GA; Castillo Silva BE; Sámano Valencia C; Salas Orozco MF
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34068221
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection is associated with higher odds of insulin treatment but not with hemoglobin A1c at 120 days in U.S. Veterans with new-onset diabetes.
Wander PL; Lowy E; Korpak A; Beste LA; Kahn SE; Boyko EJ
Diabet Epidemiol Manag; 2023; 11():100151. PubMed ID: 37333508
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Negative Factors for the Clinical Outcome in Patients with SARS-CoV-2 Infection and Type 2 Diabetes Mellitus.
Albai O; Braha A; Timar B; Sima A; Deaconu L; Timar R
Diabetes Metab Syndr Obes; 2024; 17():271-282. PubMed ID: 38283636
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection in hospitalized children with type 1 and type 2 diabetes.
Trieu C; Sunil B; Ashraf AP; Cooper J; Yarbrough A; Pinninti S; Boppana S
J Clin Transl Endocrinol; 2021 Dec; 26():100271. PubMed ID: 34729361
[TBL] [Abstract][Full Text] [Related]
13. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study.
Wargny M; Potier L; Gourdy P; Pichelin M; Amadou C; Benhamou PY; Bonnet JB; Bordier L; Bourron O; Chaumeil C; Chevalier N; Darmon P; Delenne B; Demarsy D; Dumas M; Dupuy O; Flaus-Furmaniuk A; Gautier JF; Guedj AM; Jeandidier N; Larger E; Le Berre JP; Lungo M; Montanier N; Moulin P; Plat F; Rigalleau V; Robert R; Seret-Bégué D; Sérusclat P; Smati S; Thébaut JF; Tramunt B; Vatier C; Velayoudom FL; Vergès B; Winiszewski P; Zabulon A; Gourraud PA; Roussel R; Cariou B; Hadjadj S;
Diabetologia; 2021 Apr; 64(4):778-794. PubMed ID: 33599800
[TBL] [Abstract][Full Text] [Related]
14. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.
Agyemang C; Richters A; Jolani S; Hendriks S; Zalpuri S; Yu E; Pijls B; Prins M; Stronks K; Zeegers MP
BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34740916
[TBL] [Abstract][Full Text] [Related]
15. Baseline Cardiometabolic Profiles and SARS-CoV-2 Infection in the UK Biobank.
Scalsky RJ; Chen YJ; Desai K; O'Connell JR; Perry JA; Hong CC
medRxiv; 2020 Nov; ():. PubMed ID: 32766593
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of hospital-acquired SARS-CoV-2 infection in the Canadian first wave epicentre: a retrospective cohort study.
Melançon E; Brosseau M; Bartoli A; Labbé AC; Lavallée C; Marchand-Senécal X; Wang HT
CMAJ Open; 2022; 10(1):E74-E81. PubMed ID: 35105684
[TBL] [Abstract][Full Text] [Related]
17. Preadmission Insulin-Treated Type 2 Diabetes Mellitus Patients Had Increased Mortality in Intensive Care Units.
Fan R; Xie L; Peng X; Yu B; Zou H; Huang J; Yu X; Wang D; Yang Y
Diabetes Metab Syndr Obes; 2022; 15():2135-2148. PubMed ID: 35911502
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: A prospective cohort study.
Knudtzen FC; Jensen TG; Lindvig SO; Rasmussen LD; Madsen LW; Hoegh SV; Bek-Thomsen M; Laursen CB; Nielsen SL; Johansen IS
PLoS One; 2021; 16(10):e0258421. PubMed ID: 34637459
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study.
Lampasona V; Secchi M; Scavini M; Bazzigaluppi E; Brigatti C; Marzinotto I; Davalli A; Caretto A; Laurenzi A; Martinenghi S; Molinari C; Vitali G; Di Filippo L; Mercalli A; Melzi R; Tresoldi C; Rovere-Querini P; Landoni G; Ciceri F; Bosi E; Piemonti L
Diabetologia; 2020 Dec; 63(12):2548-2558. PubMed ID: 33029657
[TBL] [Abstract][Full Text] [Related]
20. A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection.
Ruan Y; Ryder REJ; De P; Field BCT; Narendran P; Iqbal A; Gandhi R; Harris S; Nagi D; Aziz U; Karra E; Ghosh S; Hanif W; Edwards AE; Zafar M; Dashora U; Várnai KA; Davies J; Wild SH; Wilmot EG; Webb D; Khunti K; Rea R;
Diabetologia; 2021 Aug; 64(8):1717-1724. PubMed ID: 33966090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
